Y-Intercept (HK)’s Palvella Therapeutics PVLA Stock Holding History

Y-Intercept (HK)’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-136	Closed	-$42K	–	963
2021 Q2	$42K	Buy	+136	New	+$29.8K	0.01%	564

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Y-Intercept (HK)'s PVLA Position: Q3 2021 in Review

Y-Intercept (HK) sold out of Palvella Therapeutics (PVLA) in Q3 2021, closing a stake of 136 shares — an estimated $42K sold.

Y-Intercept (HK) first reported a position in PVLA in Q2 2021 and held it in 1 quarter. The position peaked at $42K in Q2 2021. 75 funds tracked by Wall St. Rank hold PVLA as of Q3 2021.

Y-Intercept (HK) reported no remaining Palvella Therapeutics position as of Q3 2021 after selling out during the quarter.
Y-Intercept (HK) sold 136 Palvella Therapeutics shares in Q3 2021, an estimated $42K.
Y-Intercept (HK) first reported a position in Palvella Therapeutics in Q2 2021 and held it in 1 quarter.
Y-Intercept (HK)'s Palvella Therapeutics position peaked at $42K in Q2 2021.
75 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2021.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.